Moderna mRNA flu vaccine beats standard shot, awaits FDA review

🌐 USA Today —
Moderna mRNA flu vaccine beats standard shot, awaits FDA review

AI Summary

The Moderna mRNA flu vaccine has demonstrated superior efficacy compared to the standard flu shot and is currently awaiting review by the FDA. This new vaccine aligns with advancements in vaccine technology following the success of the COVID-19 mRNA vaccines.

Health Moderna mRNA vaccine flu vaccine FDA healthcare vaccination

Read original source →